Heart risks to be reviewed as Cdn. firm's diabetes drug faces scrutiny in US

WASHINGTON (AP) - U.S. government health advisers are being asked Monday to consider whether heart risks associated with the widely used diabetes drug Avandia outweigh its benefits....More